AzTrials
AzTrials

Myocardial Infarction, AcuteNCT05285969

Cardiac Rehabilitation With Motivational Interview for Acute Myocardial Infarction

A study testing Motivational interview in people with Myocardial Infarction, Acute, run by Consorci d'Atenció Primària de Salut de l'Eixample at 4 sites in Spain.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Introduction: Secondary prevention after acute myocardial infarction may include cardiac rehabilitation and lifestyle changes. Cardiac rehabilitation has mainly taken place in hospitals without coordination with primary healthcare. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Myocardial Infarction, Acute
What is being tested?
Motivational interview
Could I receive a placebo?
No, everyone receives an active treatment
How many people
284 participants
Where
4 sitesSpain
Study dates
1 Apr 2022to 1 Dec 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age >18 years.
  • Hospital admission for acute coronary syndrome (diagnostic codes ICD-10: I20-I22).
  • Post unscheduled cardiac revascularization surgery (procedure code ICD-10: 021x).
  • Discharge to home with the area of the 7 PHCs.
  • Indication of RC indication.
  • Voluntary participation.

Who cannot join

  • Acute aortic disease,
  • Severe pulmonary hypertension.
  • Uncontrolled arrhythmias.
  • Decompensated Heart Failure or significant valvular or congenital heart disease.
  • Intervention in heart valves and/or interventricular septum.
  • Diseases that prevent exercise.
Show all 12Show fewer
  • Osteoarticular disease that severely limits exercise.
  • Severe mental disorder.
  • Any severe psychiatric disorders.
  • Cognitive disability.
  • Verbal communication problems.
  • Participation in hospital Cardiac Rehabilitation.

Trial locations and contacts

4 sites in 1 country.

Luis González de Paz, PhD contact

0034 932275683

lgonzale@clinic.cat

Rocío Rodríguez Romero, RN contact

0034932279800 ext. 381179

rorodri@clinic.cat

Spain4 sites, 4 recruiting
  • Centre Atenció Primària de Les Corts

    Barcelona, 08028

    Luis González de Paz, PhD

    Recruiting
  • CAP Compte Borrell

    Barcelona, 08029

    Noemí García-Planes, R.N.

    Not yet recruiting
  • Centre Atenció Primària Montengre

    Barcelona, 08029

    Juan J. Zamora, RN

    Recruiting
  • Centre Atenció Primària Casanova

    Barcelona, 08036

    Rocio Rodríguez Romero, BSN

    Recruiting

Other trials in Spain

About this study

Official title: Motivational Interview for Cardiac Rehabilitation in Acute Myocardial Infarction: A Randomized Controlled Trial in the Primary Healthcare Area.

Introduction: Secondary prevention after acute myocardial infarction may include cardiac rehabilitation and lifestyle changes. Cardiac rehabilitation has mainly taken place in hospitals without coordination with primary healthcare. Motivational interviews have been shown to be effective as a means for change in patients after acute myocardial infarction. The objective of this study is to evaluate the effectiveness of a cardiac rehabilitation program with motivational interviews in patients discharged from hospital after acute myocardial infarction.

Methods: Randomized clinical non-pharmacological trial. A minimum sample of 284 participants requiring cardiac rehabilitation after acute myocardial infarction in six primary healthcare centers. Participants will be randomized to cardiac rehabilitation with motivational interviews or normal standard of care. All secondary results will be evaluated at 1,3 and 6 months.

Being tested
Motivational interview, Active Comparator: Standard care group
Keywords
Myocardial Infarction, Cardiac Rehabilitation, Rehabilitation Nursing, Primary Health Care, Motivational Interviewing
Medical subject headings
Myocardial Infarction

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Motivational interviewBehavioural

    The new CR program with MI will be structured in 4 sessions and an optional fifth during the six months after discharge. The methodology of the MI sessions will follow the four phases logical sequence of MI proposed by Rollnick and Millner. 1) engage in a collaborative relationship, 2) focus on a particular change, 3) evoke intrinsic motivations for change, and 4) plan an immediate step for change

  • Active Comparator: Standard care groupBehavioural

    All patients in the control group will receive a kit with informative material with the actions and procedures to follow (diet, physical activity, smoking cessation, and other recommendations about secondary prevention).

Study groups in NCT05285969
Study groupRoleWhat they receive
Motivational interviewExperimentalMotivation Interview program with standard care
Receives: Behavioral: Motivational interview
Standard care groupActive comparatorStandard care
Receives: Behavioral: Active Comparator: Standard care group

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Physical functional capacity

    Improvement in aerobic capacity and resistance, measured by a physical effort test

    Measured: 1st month

  2. Physical functional capacity

    Improvement in aerobic capacity and resistance, measured by a physical effort test

    Measured: 6th month

Secondary outcomes (7)
  1. Effectiveness of secondary prevention

    Effectiveness of secondary prevention will be considered (Satisfied / no satisfied) with next conditions (all together):

    Blood pressure values <140/90mmHg, plasma cholesterol c-LDL<70mg/dL, plasma glycosylated hemoglobin <7%. Absolute cessation or no initiation of smoking Body Mass Index in the range of 18.5-25kg/m^2.

    Measured: 1st month

  2. Effectiveness of secondary prevention

    Effectiveness of secondary prevention will be considered (Satisfied / no satisfied) with next conditions (all together):

    Blood pressure values <140/90mmHg, plasma cholesterol c-LDL<70mg/dL, plasma glycosylated hemoglobin <7%. Absolute cessation or no initiation of smoking Body Mass Index in the range of 18.5-25kg/m^2.

    Measured: 3rd month

  3. Effectiveness of secondary prevention

    Effectiveness of secondary prevention will be considered (Satisfied / no satisfied) with next conditions (all together):

    Blood pressure values <140/90mmHg, plasma cholesterol c-LDL<70mg/dL, plasma glycosylated hemoglobin <7%. Absolute cessation or no initiation of smoking Body Mass Index in the range of 18.5-25kg/m^2.

    Measured: 6th month

  4. Psychological status

    Measured with the Psychological General Well-Being Index (PGWBI)

    Measured: 6th month

  5. Perceived quality of life

    Physical and mental summaries of perceived quality of life measured with the generic quality of life Short Form questionnaire (SF-12).

    Measured: 1st month

  6. Perceived quality of life

    Physical and mental summaries of perceived quality of life measured with the generic quality of life Short Form questionnaire (SF-12).

    Measured: 2nd month

  7. Perceived quality of life

    Physical and mental summaries of perceived quality of life measured with the generic quality of life Short Form questionnaire (SF-12).

    Measured: 3rd month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Mar 2022
  2. Study start1 Apr 2022
  3. Primary completion1 Oct 2025 (estimated)
  4. Study completion1 Dec 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
284 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05285969
Sponsor's protocol ID
HCB/2019/0727
Status last verified
Mar 2023
First submitted
28 Feb 2022
Last updated
29 Mar 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Bjarnason-Wehrens B, McGee H, Zwisler AD, Piepoli MF, Benzer W, Schmid JP, Dendale P, Pogosova NG, Zdrenghea D, Niebauer J, Mendes M; Cardiac Rehabilitation Section European Association of Cardiovascular Prevention and Rehabilitation. Cardiac rehabilitation in Europe: results from the European Cardiac Rehabilitation Inventory Survey. Eur J Cardiovasc Prev Rehabil. 2010 Aug;17(4):410-8. doi: 10.1097/HJR.0b013e328334f42d.

    PubMed 20300001
  • Abreu A, Pesah E, Supervia M, Turk-Adawi K, Bjarnason-Wehrens B, Lopez-Jimenez F, Ambrosetti M, Andersen K, Giga V, Vulic D, Vataman E, Gaita D, Cliff J, Kouidi E, Yagci I, Simon A, Hautala A, Tamuleviciute-Prasciene E, Kemps H, Eysymontt Z, Farsky S, Hayward J, Prescott E, Dawkes S, Pavy B, Kiessling A, Sovova E, Grace SL. Cardiac rehabilitation availability and delivery in Europe: How does it differ by region and compare with other high-income countries?: Endorsed by the European Association of Preventive Cardiology. Eur J Prev Cardiol. 2019 Jul;26(11):1131-1146. doi: 10.1177/2047487319827453. Epub 2019 Feb 20.

    PubMed 30782007
  • Martín R. Efectividad de la rehabilitación cardíaca en un grupo de pacientes de alto riesgo. Rev Enferm Cardiol. 2018;25(75):34-39.

  • Shields GE, Wells A, Doherty P, Heagerty A, Buck D, Davies LM. Cost-effectiveness of cardiac rehabilitation: a systematic review. Heart. 2018 Sep;104(17):1403-1410. doi: 10.1136/heartjnl-2017-312809. Epub 2018 Apr 13.

    PubMed 29654096
  • Piepoli MF, Corra U, Adamopoulos S, Benzer W, Bjarnason-Wehrens B, Cupples M, Dendale P, Doherty P, Gaita D, Hofer S, McGee H, Mendes M, Niebauer J, Pogosova N, Garcia-Porrero E, Rauch B, Schmid JP, Giannuzzi P. Secondary prevention in the clinical management of patients with cardiovascular diseases. Core components, standards and outcome measures for referral and delivery: a policy statement from the cardiac rehabilitation section of the European Association for Cardiovascular Prevention & Rehabilitation. Endorsed by the Committee for Practice Guidelines of the European Society of Cardiology. Eur J Prev Cardiol. 2014 Jun;21(6):664-81. doi: 10.1177/2047487312449597. Epub 2012 Jun 20.

    PubMed 22718797
  • Verbo E. Protocolo de rehabilitación cardiaca en pacientes con insuficiencia cardiaca (Tesis). Universidad CEU-San Pablo. 2012.

  • Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, Falk V, Gonzalez-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GMC, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P; ESC Scientific Document Group. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016 Jul 14;37(27):2129-2200. doi: 10.1093/eurheartj/ehw128. Epub 2016 May 20. No abstract available.

    PubMed 27206819
  • Kotseva K, Wood D, De Bacquer D, De Backer G, Ryden L, Jennings C, Gyberg V, Amouyel P, Bruthans J, Castro Conde A, Cifkova R, Deckers JW, De Sutter J, Dilic M, Dolzhenko M, Erglis A, Fras Z, Gaita D, Gotcheva N, Goudevenos J, Heuschmann P, Laucevicius A, Lehto S, Lovic D, Milicic D, Moore D, Nicolaides E, Oganov R, Pajak A, Pogosova N, Reiner Z, Stagmo M, Stork S, Tokgozoglu L, Vulic D; EUROASPIRE Investigators. EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries. Eur J Prev Cardiol. 2016 Apr;23(6):636-48. doi: 10.1177/2047487315569401. Epub 2015 Feb 16.

    PubMed 25687109
  • Haykowsky M, Scott J, Esch B, Schopflocher D, Myers J, Paterson I, Warburton D, Jones L, Clark AM. A meta-analysis of the effects of exercise training on left ventricular remodeling following myocardial infarction: start early and go longer for greatest exercise benefits on remodeling. Trials. 2011 Apr 4;12:92. doi: 10.1186/1745-6215-12-92.

    PubMed 21463531
  • Bohplian S, Bronas UG. Motivational Strategies and Concepts to Increase Participation and Adherence in Cardiac Rehabilitation: AN INTEGRATIVE REVIEW. J Cardiopulm Rehabil Prev. 2022 Mar 1;42(2):75-83. doi: 10.1097/HCR.0000000000000639.

    PubMed 34753873
  • Sociedad Española de Cardiología. Registro Nacional de Unidades de Rehabilitación Cardíaca. R- EUReCa. Available from: https://secardiologia.es/riesgo/cientifico/6415-registro-nacional-de-unidades-de-rehabilitacion- cardiaca-r-eureka (accessed 30 Jan 2019).

  • Rodrigo-Banos V, Moral-Pairada MD, Gonzalez-de Paz L. A Comprehensive Assessment of Informal Caregivers of Patients in a Primary Healthcare Home-Care Program. Int J Environ Res Public Health. 2021 Nov 4;18(21):11588. doi: 10.3390/ijerph182111588.

    PubMed 34770102
  • Gene-Badia J, Ascaso C, Escaramis-Babiano G, Sampietro-Colom L, Catalan-Ramos A, Sans-Corrales M, Pujol-Ribera E. Personalised care, access, quality and team coordination are the main dimensions of family medicine output. Fam Pract. 2007 Feb;24(1):41-7. doi: 10.1093/fampra/cml056. Epub 2006 Nov 1.

    PubMed 17079249
  • Pujol Ribera E, Gene Badia J, Sans Corrales M, Sampietro-Colom L, Pasarin Rua MI, Iglesias-Perez B, Casajuana-Brunet J, Escaramis-Babiano G. [Primary health care product defined by health professionals and users]. Gac Sanit. 2006 May-Jun;20(3):209-19. doi: 10.1157/13088852. Spanish.

    PubMed 16756859
  • Palomo L, Gene-Badia J, Rodriguez-Sendin JJ. [The reform of primary care, between the last refuge of adventure and innovation. SESPAS report 2012]. Gac Sanit. 2012 Mar;26 Suppl 1:14-9. doi: 10.1016/j.gaceta.2011.06.010. Epub 2011 Oct 11. Spanish.

    PubMed 21996448

Questions about this trial

What is this clinical trial studying?

A study testing Motivational interview in people with Myocardial Infarction, Acute, run by Consorci d'Atenció Primària de Salut de l'Eixample at 4 sites in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 29 Mar 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 4 sites in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Luis González de Paz, PhD (0034 932275683, lgonzale@clinic.cat), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Physical functional capacity (time frame: 1st month). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05285969, which also lists 33 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Mar 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in